Mia's Feed
Medical News & Research

The Brain's Prediction of Infections Can Activate the Immune System Even Virtually

The Brain's Prediction of Infections Can Activate the Immune System Even Virtually

Share this article

New research reveals that the brain's anticipation of infection can trigger immune responses even in virtual environments, uncovering a proactive neuro-immune mechanism that enhances early defense against pathogens.

2 min read

Recent research by scientists from the University of Geneva and École Polytechnique Fédérale de Lausanne highlights a fascinating aspect of human immunity: our brain's ability to anticipate potential infections and trigger immune responses without actual exposure. In a groundbreaking study published in Nature Neuroscience, researchers demonstrated that neural anticipation, especially in virtual reality settings, can activate innate lymphoid cells (ILCs), which are critical for early immune defense.

Innate lymphoid cells are immune responders that act swiftly in the face of microbial threats, without needing prior antigen recognition. Traditionally, immune activation was thought to occur primarily after physical contact with pathogens. However, this new study provides evidence that the immune system can preemptively mobilize based on neural signals indicating an infection threat.

The experiment involved 60 healthy adults divided into groups exposed to different virtual avatars representing infectious, neutral, or fearful entities. Using advanced techniques such as EEG, fMRI, mass spectrometry, and flow cytometry, the team tracked neural and immune responses. Participants exposed to infectious avatars exhibited increased reaction times in tactile tests, indicating an expansion of the peripersonal space—an area around the body that signals threat. Neural activity was observed in multisensory and motor brain regions, including the salience network, insula, and prefrontal cortex.

Moreover, immune analysis revealed virtual infections modulated ILC activity similar to real infections, with decreased ILC1s and increased ILC2s and precursor cells, suggesting the immune system was preparing for potential invasion. Brain imaging localized these anticipatory responses to specific regions, and connectivity analyses linked neural activity to hypothalamic pathways that regulate immune responses.

This study implies that the human neuro-immune system works proactively, activating defenses when it perceives a threat—even in a virtual scenario. Such anticipatory mechanisms could provide substantial survival advantages by enabling rapid immune activation before actual exposure to pathogens.

Overall, these findings revolutionize our understanding of immunity, emphasizing the importance of brain-immune communication and opening new avenues for immune modulation strategies in medicine.

Source: https://medicalxpress.com/news/2025-07-virtual-infectious-pathogen-prompt-real.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Revolutionary AI Imaging Tech Significantly Reduces Radiation Exposure in Medical Diagnostics

HKUST has developed an AI-powered imaging technology that reduces radiation exposure by up to 99%, enabling faster, safer, and more cost-effective medical diagnostics with minimal X-ray images.

A Holistic Approach to Menopause: Education, Workplace Support, and Research Initiatives

A multifaceted approach encompassing education, workplace policies, and research is vital to improve women's experiences during menopause and reduce associated stigma and health disparities.

New Insights Into CDK12 Gene Inactivation as a Key Driver of Aggressive Ovarian Cancer

New research highlights the critical role of CDK12 gene inactivation in driving aggressive ovarian cancer, paving the way for innovative targeted therapies and improved outcomes.

New Approach for Treating Resistant Blood Cancers by Blocking CD200R1 Protein

Scientists have discovered that blocking the CD200R1 protein can activate immune cells to fight treatment-resistant blood cancers, paving the way for novel therapies.